Huntington's disease (HD) is a fatal, inherited neurodegenerative disorder that is characterized by disturbances in movement, cognition, and personality. The mutation that causes HD is an expansion of CAG repeats [encoding polyglutamine (polyQ)] in the gene IT-15 (which encodes the huntingtin protein) (1). Parkinson's disease (PD) is a major neurodegenerative disorder characterized by muscle rigidity, bradykinesia, resting tremor, and postural instability (2) . Although the vast majority of cases of PD are idiopathic, a small percentage are caused by missense mutations of the ␣-synuclein gene (3, 4) . One neuropathological feature shared by HD and PD is the occurrence of ubiquitinated intraneuronal inclusion bodies in diseased brains. Huntingtin, and/or truncation products of huntingtin, are the major components of cytoplasmic and nuclear inclusion bodies observed in HD, and ␣-synuclein is the major component of inclusion bodies (Lewy bodies) in PD. Huntingtin (5) and ␣-synuclein (6) assemble into fibrillar protein aggregates that display many properties of amyloid in vitro and in vivo. The precise roles of protein aggregation, amyloid formation, and inclusion bodies in HD, PD, and other amyloid diseases remain controversial, and it is not clear whether common pathogenic mechanisms occur in these disorders.
Here, we have used the baker's yeast Saccharomyces cerevisiae as a model eukaryotic organism to test the hypothesis that the downstream targets and molecular mechanisms by which a mutant huntingtin fragment and ␣-synuclein mediate toxicity are distinct. Similar to neurons, yeast transformed with mutant huntingtin fragments form inclusion bodies in a process regulated by yeast homologs of Hsp40 and Hsp70 (7, 8) . As in many types of mammalian cells, overexpression of mutant huntingtin fragments in yeast has no effect on cell viability. This feature allows genetic screens to be performed to identify genes that unmask, or enhance, toxicity. Here, we have used a yeast gene deletion set (YGDS) of 4850 viable mutant haploid strains (9, 10) to identify genes that enhance toxicity of a mutant huntingtin fragment or ␣-synuclein. In our model of huntingtin inclusion body formation in S. cerevisiae (8) , yeast are transformed with constructs that express exon 1 of the huntingtin gene with a normal (HD20Q) and expanded (HD53Q) polyQ repeat under control of the CUP1 promoter. The aggregation and inclusion body-forming properties of huntingtin fragments with expanded polyQ tracts can be reproduced faithfully in S. cerevisiae (8) . Similarly, overexpression of wild-type or mutant (A53T) human ␣-synuclein in yeast results in the formation of cytoplasmic inclusion bodies that, at the level of light microscopy, are similar to those formed by mutant huntingtin fragments in yeast (11) .
A collection of 4850 yeast strains was transformed with constructs that express HD53Q or ␣-synuclein under the control of inducible promoters and was plated onto selective media in the absence of induction (12) . Mutants that were sensitive to a HD53Q or ␣-synuclein were isolated by replica plating onto media that contained the appropriate inducer of protein expression. We confirmed putative HD53Q-or ␣-synuclein-sensitive mutants by retesting isolated colonies in spotting assays that measure cell viability (Fig. 1) . Although positive colonies were selected originally because of their complete lack of growth (synthetic lethality) after induction, the retests indicated that a sublethal effect on toxicity (synthetic sickness) occurred in , or HD53Q were grown in liquid synthetic complete medium lacking uracil (SC-URA) to log phase and then induced for 24 hours in SC-URA ϩ copper. Samples of cells were removed from liquid cultures before ( T ϭ 0) and after ( T ϭ 24 hours) copper induction, were spotted on plates containing SC-URA Ϯ 400 M copper, and were incubated at 30°C for 3 days. Shown are fivefold serial dilutions starting with equal numbers of cells. Spotting assays derived from single transformants for 10 unique deletion strains and the parental control strain (BY4741) are shown. (B) Yeast cells transformed with empty vector (p426GAL) or ␣-synuclein (␣-syn) were grown in liquid synthetic complete medium lacking uracil (SC-URA ϩ glucose) to log phase and then induced for 6 hours in SC-URA ϩ galactose. Samples of cells were removed from liquid cultures before ( T ϭ 0) and after ( T ϭ 6 hours) galactose induction, were spotted on plates containing SC-URA Ϯ galactose, and were incubated at 30°C for 3 days. Shown are fivefold serial dilutions starting with equal numbers of cells. Spotting assays derived from single transformants for nine unique deletion strains and the parental control strain (BY4741) are shown. many of the deletion strains (Fig. 1) . Of 4850 mutants, 52 (ϳ1%) were identified with enhanced toxicity of HD53Q, and 86 (ϳ2%) with enhanced toxicity of wild-type ␣-synuclein (Tables 1 and 2 ). Although overexpression of ␣-synuclein caused a modest decrease in cell viability in wildtype yeast (BY4741), all mutant strains that enhanced ␣-synuclein toxicity had a phenotype that was more severe than that observed in wild-type yeast (Fig. 1B) .
Of the HD53Q-sensitive mutants, 77% (40/52) corresponded to genes for which a function or genetic role has been determined experimentally or can be predicted (Table 1 ) (13) . Thirty-five percent (14/40) of these genes clustered in the functionally related categories of response to stress, protein folding, and ubiquitin-dependent protein catabolism, based on annotations in the Yeast Proteome Database ( Fig. 2 ) (14). The remaining genes were dispersed among numerous and diverse functional categories (Fig. 2 ). Fiftytwo percent (27/52) of the genes we identified are annotated as having human orthologs (Table 1) , a value that is significantly higher than the percentage of genes in the yeast genome with mammalian orthologs (ϳ31%, P Յ 1 ϫ 10 -10 ) (15). We next characterized the effects of HD20Q overexpression in yeast gene deletion strains sensitive to HD53Q. About 77% (40/52) of the deletion strains transformed with HD20Q displayed wild-type viability or exhibited a slight decrease in cell viability (table S1). Although 23% (12/52) of strains transformed with HD20Q displayed a noticeable loss of viability, in each case the phenotype was equivalent to or less severe than that observed with HD53Q ( S2 ). No correlation between levels of aggregation and viability was observed in these strains ( fig. S2 ).
Of the ␣-synuclein-sensitive mutants that were identified in the yeast screen, 66% (57/ 86) corresponded to genes for which a function or genetic role has been determined experimentally or can be predicted (Table 2) . Thirty-two percent (18/57) of these genes clustered in the functionally related categories of lipid metabolism and vesicle-mediated transport (Fig. 2) . As with the HD53Q screen, the remaining genes in the ␣-synuclein screen were distributed among numerous functional categories (Fig. 2) , and a high percentage of the genes (50% or 43/86) have human orthologs ( Table 2 ).
Evidence increasingly suggests that genes involved in response to stress, protein folding, and the ubiquitin-mediated protein catabolism play important roles in HD and the polyQ disorders (16, 17) . Overexpression of the chaperones Hsp40 and/or Hsp70 in fruit fly and mouse models of polyQ disorders suppresses neurodegeneration, whereas mutation of genes involved in ubiquitinmediated protein catabolism enhances neurodegeneration (18) (19) (20) (21) (22) . Our yeast screen identified two Hsp40 homologs (Apj1 and Hlj1) that when deleted enhance toxicity of HD53Q. These results indicate that in wildtype yeast cells Hsp40 chaperones are necessary to suppress polyQ toxicity. In addition to chaperones, eight genes (FPR2, GRE2, GSH2, HLR1, PRM5, SIP18, YHB1, and YJR107W) involved in various forms of cellular stress (osmotic, oxidative, and nitrosative) and three genes involved in ubiquitinmediated protein catabolism (UBP13, YBR203W, and YKR017C) were identified as enhancers of HD53Q toxicity in yeast.
Several genes in the functional categories of response to stress and ubiquitin-mediated protein catabolism were also isolated in the ␣-synuclein screen (SOD2, GTT1, HSP30, TSL1, and UBC8) ( Table 2 ). However, in contrast to the HD53Q screen, the levels of genes in these categories were not increased above background levels (Fig. 2) . A recent study demonstrated that Hsp70 overexpression rescues ␣-synuclein-induced neurodegeneration in a Drosophila model for PD (23) . Although considerable genetic, cell biological, and biochemical evidence suggests that genes involved in response to stress, protein folding, and ubiquitin-mediated protein catabolism play important roles in the pathobiology of PD, the results from the ␣-synuclein yeast screen indicate that genes involved in lipid metabolism and vesiclemediated transport may also be primary pathways that regulate toxicity of ␣-synuclein.
␣-Synuclein localizes to nerve terminals and may be associated with synaptic vesicles, based on immunohistochemistry and ultra- (31) , which has been proposed to lead to defective sequestration of dopamine into vesicles and subsequent generation of reactive oxygen species in the cytoplasm that contribute to neuronal dysfunction and cell death (32) . Taken together, these results are consistent with those from our ␣-synuclein genetic screen and with studies examining the biological and pathobiological effects of ␣-synuclein in yeast. ␣-Synuclein, and not a mutant huntingtin fragment, localized to membranes, caused the accumulation of lipid droplets and inhibited phospholipase D and vesicular trafficking (11) . The results from the yeast screen are also consistent with recent expressionprofiling studies in Drosophila that overexpress ␣-synuclein, which showed that lipid and membrane transport mRNAs were tightly associated with ␣-synuclein expression (33) . The results from yeast screens clearly indicate that toxicity mediated by ␣-synuclein and a mutant huntingtin fragment is regulated by nonoverlapping sets of conserved genes and pathways. The major functional categories enriched in the ␣-synuclein genetic screen did not overlap with any of the major categories observed in the HD53Q screen, and only 1 out of 138 genes that enhanced toxicity was found in common to both screens (STP2). Collectively, these results suggest that distinct pathogenic mechanisms may underlie HD and PD.
Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology
Tiago Fleming Outeiro and Susan Lindquist* Alpha-synuclein is implicated in several neurodegenerative disorders, such as Parkinson's disease and multiple system atrophy, yet its functions remain obscure. When expressed in yeast, alpha-synuclein associated with the plasma membrane in a highly selective manner, before forming cytoplasmic inclusions through a concentration-dependent, nucleated process. Alpha-synuclein inhibited phospholipase D, induced lipid droplet accumulation, and affected vesicle trafficking. This readily manipulable system provides an opportunity to dissect the molecular pathways underlying normal alpha-synuclein biology and the pathogenic consequences of its misfolding.
Alpha-synuclein (␣Syn) is abundant and broadly expressed in the brain, where it interacts with membranes, vesicular structures, and a puzzling variety of other proteins (1). Some cases of Parkinson's disease (PD) have a genetic basis (2) that implicates protein folding and qualitycontrol (QC) factors, including a ubiquitin ligase (3) and a ubiquitin C-terminal hydrolase (4, 5) , in ␣Syn pathology. In mammalian cells ␣Syn has been reported in the nucleus, cytosol, associated with membranes and, in diseased brains, in large cytoplasmic inclusions (Lewy bodies) (1) . Synucleinopathies are now classified as protein-misfolding disorders (6) . Given the strong conservation of protein folding, membrane trafficking, and protein QC mechanisms between yeast and higher eukaryotes, we used Saccharomyces cerevisiae to uncover and establish basic aspects of both normal and abnormal ␣Syn biology.
To study ␣Syn dynamics in living cells, we created an ␣Syn-GFP (green fluorescent protein) fusion that was not subject to proteolysis in yeast cells (Fig. 1A) (7) as related fusions have been in mammalian cells (8) . Integrating this construct into the genome under the control of a galactose-inducible promoter allowed routine manipulations in the absence of ␣Syn expression. Upon induction with galactose, wild-type (WT) ␣Syn-GFP localized intensely at the plasma membrane; a smaller quantity accumulated in the cytoplasm (Fig. 1B) . Compared with other GFP fusion proteins, ␣Syn did not localize to mitochondrial or nuclear membranes (9) . Thus, reminiscent of its selectivity for membranes with particular lipid compositions in vitro (10) , ␣Syn has a high intrinsic selectivity for particular cellular membranes in vivo.
Two ␣Syn point mutants (A53T and A30P) are associated with rare forms of early-onset familial PD but have distinct physical properties (11, 12) . In yeast, each ␣Syn mutant accumulated at the same level as WT ␣Syn (Fig.  1A, one copy) 
